in vitro studies based on periodic viable count determinations indicated that the two antifungal drugs ketoconazole and 5-fluorocytosine generally were at least additive in their combined effect on various opportunistic yeast pathogens , including some resistant to 5-fluorocytosine .
C0003308
antifungal drugs
C0016278
5-fluorocytosine